Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis C Virus Vaccines
New hepatitis C virus vaccines data have been reported by scientists at Technical University, Institute of Virology
April 16th, 2008
A new study, 'Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model,' is now available. According to recent research from Germany, "Efficient vaccines against hepatitis C virus (HCV) infection are urgently needed. Vaccine development has been hampered by the lack of suitable small animal models to reliably test the protective capacity of immmunization." "We used recombinant murine gammaherpesvirus 68 (MHV-68) as a novel challenge virus in mice and tested the efficacy of heterologous candidate human vaccines based on modified vaccinia virus Ankara or adenovirus, both delivering HCV non-structural NS3 or core proteins....
Source: Vaccine Weekly (2008-04-16)
|
